Korean J Ophthalmol.  2011 Feb;25(1):63-65. 10.3341/kjo.2011.25.1.63.

The Development of Recurrent Choroidal Neovascularization in a Patient with Choroidal Coloboma

  • 1Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea.
  • 2Department of Ophthalmology, Chonnam National University Hospital, Gwangju, Korea.
  • 3Research Institute for Sensory Organs, Medical Research Center, Seoul National University, Seoul, Korea. hgonyu@snu.ac.kr


We report a case of recurrent choroidal neovascularization (CNV) in an eye with chorioretinal coloboma. A 36-year-old woman presented complaining of decreased visual acuity (VA) in her left eye. Best corrected visual acuity (BCVA) was 20/200 and iris coloboma was observed. Funduscopy and fluorescein angiography (FA) showed CNV in the superior extrafoveal region with chorioretinal coloboma reaching just inferior to the optic disc. No other cause for CNV was observed except for the chorioretinal coloboma. BCVA improved to 20/30 after laser photocoagulation. She revisited our clinic for deteriorating VA (20/400) in the same eye 3 years after treatment. Funduscopy and FA demonstrated recurrent CNV with subfoveal hemorrhage. Photodynamic therapy (PDT) was followed by three consecutive intravitreal bevacizumab injections (IVB) for the subfoveally-located CNV. However, the CNV persisted with the appearance of a fresh subretinal hemorrhage. Additional PDT was combined with IVB on the same day 6 months after the initial PDT. The CNV regressed 3 months after treatment and has not recurred as of 8 months after the last treatment. The patient's BCVA improved to 20/60. This case suggests that PDT combined with IVB can be an alternative treatment for the management of recurrent CNV after laser photocoagulation in eyes with chorioretinal coloboma.


Bevacizumab; Choroidal coloboma; Choroidal neovascularization; Photochemotherapy
Full Text Links
  • KJO
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr